The physical impacts of COPD are quite well known, but the mental impacts often go unnoticed and undiagnosed.
The paper, “Anxiety, Depression, and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease,” sought to examine just how prevalent these conditions are among patients with COPD. It was published in the Indian Journal of Chest Diseases and Allied Sciences.
The researchers conducted a narrative analysis of contemporary literature between 2010 and 2025 including systematic reviews, meta-analyses, randomized controlled trials and pertinent observational studies. They found that 25–40% of stable patients with COPD also have clinically significant depressive symptoms, and 20–46% have anxiety. Both conditions correlate strongly with poorer quality of life, including increased exacerbations, hospital admissions, worse adherence to medications and higher mortality.
More specifically, they found that dyspnea (shortness of breath) is a powerful driver of anxiety that produces panic-like responses and fear of suffocation. Recurrent breathlessness and fear of exacerbations can contribute to social withdrawal, which in turn contributes to increased depressive symptoms.
In addition, reduced physical activity and exercise intolerance can produce deconditioning, which worsens breathlessness. This can cause a downward spiral of inactivity and low mood swings. The depression caused by this can further reduce the motivation of the patient to adhere to treatment.
The researchers suggested several management strategies that may benefit patients with these conditions, such as:
- Pulmonary rehabilitation and exercise, which is known to reduce both exacerbations and anxiety
- Psychological therapies, such as cognitive behavioral therapy, mindfulness-based interventions and counseling
- Pharmacotherapy, including antidepressants and anxiolytics to help treat comorbid mood and anxiety disorders
- Self-management and education on disease prognosis, inhaler techniques, exacerbation and action plans to reduce uncertainty and alleviate anxiety
- Social- and system-level interventions to address social determinants, such as financial strain, caregiver support and access to treatment to help reduce these contributors to psychological stress
“Anxiety and depression substantially degrade quality of life in COPD,” the researchers wrote. “Routine screening and integrated management — combining pulmonary, psychological and social care — are essential.”
